Do you offer adjuvant androgen deprivation therapy for AR+ salivary ductal carcinomas treated with curative intent?
1 Answer
Mednet Member
Radiation Oncology · University of Oklahoma Health Sciences Center
Answered on · Updated on
There is a recently released ASCO guideline [Geiger et al., PMID 33900808] which specifically addresses the role of systemic therapy in the management of salivary gland malignancies.
Regarding systemic therapy, the recent ASCO guideline suggests concurrent chemotherapy, HER2-Neu targeted therapies, a...
Join for free or sign in to see the full answer